The Australian Government's Innovation Report
The Australian Government's Innovation Report
The Australian Government's Innovation Report
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Vision CRC<br />
International collaboration between scientists and industry is helping contact-lens<br />
wearers maintain eye health.<br />
<strong>The</strong> Vision Cooperative Research Centre is a great example of the sort of successful<br />
innovation produced by the Cooperative Research Centre Programme, which<br />
maximises the benefits of research through an enhanced process of utilisation,<br />
commercialisation and technology transfer.<br />
<strong>The</strong> 020PTIX contact-lens, developed through a collaboration of the Vision<br />
Cooperative Research Centre and one of its partners, CIBA Vision, has been a<br />
massive success in the US$4.6 billion global contact-lens market.<br />
020PTIX contact-lens. Photo credits: Vision CRC<br />
<strong>The</strong> lens is designed for people who usually wear contact-lenses during the day, but want the option of<br />
occasional overnight wear. O2OPTIX transmits considerably more oxygen to the eye of the wearer than<br />
traditional soft lenses, which helps to maintain eye health.<br />
<strong>The</strong> sales of O2OPTIX and NIGHT & DAY contact-lenses, also developed by the same team, generated<br />
US$10 million in royalties for the Vision Cooperative Research Centre in 2004-05. That figure is expected<br />
to rise significantly over the life of the patents, which extend to 2014.<br />
World Class Centres of Excellence – Biotechnology: <strong>Australian</strong> Stem Cell Centre<br />
<strong>The</strong> Biotechnology Centre of Excellence, the <strong>Australian</strong> Stem Cell Centre (ASCC), is the flagship biotechnology<br />
initiative of the 2001 Backing Australia’s Ability. ASCC will receive $98.55 million over nine years to 2011 through<br />
a joint funding arrangement between the Department of Industry, Tourism and Resources and the <strong>Australian</strong><br />
Research Council.<br />
ASCC is undertaking cutting-edge, product-based research using four platform technologies: adult stem cell research,<br />
human embryonic stem cell research, tissue repair, and immune system technology. It is establishing a critical<br />
mass of leading national and international researchers and forging new partnerships with institutions and companies.<br />
At 30 April 2006, the centre had identified 35 research projects to fund. <strong>The</strong>se projects align with its scientific and<br />
commercialisation objectives under the deed of agreement with the <strong>Australian</strong> Government.<br />
<strong>The</strong> centre, headquartered in Melbourne, has funded research in four states. Institutions hosting research<br />
activities include Monash University, University of Queensland, the Victor Chang Cardiac Research Institute,<br />
the Murdoch Children’s Research Institute and Adelaide University.<br />
Highlights over the past year include:<br />
• In September 2005, collaboration was announced with the CRC for Polymers to develop smart surfaces<br />
for use in bioreactors that will provide new and improved ways of culturing and differentiating cells.<br />
A new technology combining immune system research and stem cell know-how is also being developed<br />
under a tripartite agreement between Monash University, the ASCC and Norwood Immunology.<br />
• ASCC scientists published a Nature Biotechnology paper in February 2006, which detailed the discovery<br />
of a new method of detecting abnormal embryonic stem cells before they change into cancerous cells<br />
– a discovery which could overcome a major challenge facing this field of research.<br />
• A new international collaboration in stem cell research between ASCC, Monash University and<br />
University of California, San Diego was announced in April 2006. <strong>The</strong> collaboration will bring together<br />
more than 300 leading scientists in regenerative medicine and stem cell science and will underpin major<br />
collaborations between Victoria and California. Under the initiative, the institutions will organise scientist<br />
exchanges, host joint workshops, develop joint grant applications, share equipment and materials, and<br />
establish joint clinical trials and commercial developments.<br />
• By May 2006, ASCC had awarded a total of 11 premier scholarships (up to $25 000 a year) and 14 small<br />
postgraduate research stipends (up to $10 000 a year). It had also provided a number of travel grants<br />
and conference awards.<br />
More information about the ASCC can be found at: www.stemcellcentre.edu.au<br />
Chapter 2 - Initiatives for a dynamic national innovation system 75